The Process Of Drug Designing In Modern Times: An Analytical Study
Main Article Content
Abstract
Any chemical substance that enters your body and causes a physiological effect is known as a drug. These may be administered orally or via injection. The pharmaceutical industry revolves around finding novel strategies for drug designing and development, and much has changed since the inception of this field. Today, drug designing is mostly based on computational methods such as computer aided drug designing and molecular docking. These computational methods have revolutionised the drug development process by making it less time-consuming and expensive conventional drug discovery methods. They also allow for a far more targeted methodology to drug design, increasing the probability of success in clinical trials. Additionally, the application of artificial intelligence (AI) in the hunt for novel medicines is rapidly making inroads. An enormous amount of information can be quickly sorted through by machine learning algorithms to find potential leads and create innovative molecules with desirable properties. One cannot imagine a world without drugs; therefore, it is imperative to keep enhancing the process to reach new zeniths of development. This paper aims to discuss and analyse the current process of drug designing.
Article Details
All articles published in NVEO are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.